novavax - Search News

The US Food and Drug Administration has delayed granting full approval of Novavax’s Covid-19 vaccine despite it being on track to be cleared until Tuesday afternoon, a person familiar with the situation told CNN.

· 1d · on MSN

FDA Punts on Major Covid-19 Vaccine Decision After Ouster of Top Official

The agency is sitting on a decision to grant full approval for Novavax’s shot, days after top vaccine regulator pushed out.

· 1d · on MSN

FDA misses deadline for decision on Novavax's COVID-19 vaccine, source says

The U.S. Food and Drug Administration has missed its deadline for making a decision on traditional approval for Novavax's COVID-19 vaccine, a source familiar with the matter told Reuters on Wednesday.

13h

Novavax Inc. stock underperforms Thursday when compared to competitors

Shares of Novavax Inc. NVAX slid 6.35% to $5.60 Thursday, on what proved to be an all-around dismal trading session for the ...

Fierce Pharma15h

Amid FDA tumult, agency misses decision deadline on Novavax's COVID shot

Amid a period of great upheaval at the agency, the FDA has missed its deadline to decide on approval for Novavax’s COVID-19 ...

The Pharma Letter55m

$175 million milestone in jeopardy as FDA delays Novavax nod

US biotech Novavax (Nasdaq: NVAX) is still waiting on a decision from the Food and Drug Administration over full approval of its protein-based COVID-19 vaccine, despite the agency having set an April ...

17h

FDA Delays Full Approval Decision On Novavax's COVID-19 Vaccine (UPDATED)

Novavax's COVID-19 vaccine received FDA Emergency Use Authorization, but full approval faces delays as regulators request more data beyond the April 1 deadline.